BIOTECanada’s Peter Benders on the state of the sector
July 13, 2010 by guest · Leave a Comment
What top three big-picture issues face biotech firms in Canada in the foreseeable future? Top of the list is, of course, financing. Even after an economically difficult year that saw global markets shy away from “risky” investments like biotech, within the industry, much scepticism remains about capital coming back. On the one hand, we see [...]
Listen to BioTuesdays 
